BioStem Technologies, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 47 rows, 47 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2026-09-17: Reporting owner POE BRANDON; Form 4; Security Options (Right to Buy); Transaction Holding.
- 2026-09-17: Reporting owner POE BRANDON; Form 4; Security Options (Right to Buy); Transaction Holding.
- 2026-09-17: Reporting owner SMITH-VAN VURST ANDREW; Form 4; Security Options (Right to Buy); Transaction Holding.
- 2026-09-17: Reporting owner SMITH-VAN VURST ANDREW; Form 4; Security Options (Right to Buy); Transaction Holding.
BSEM insiders stock price
Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
No transaction of this security type is retained for this issuer, so the price history carries no markers. The chart is the same one every issuer renders.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-17 holding as of filing | POE BRANDON Officer (Chief Financial Officer) | 4 | Options (Right to Buy) Derivative · Direct | Holding | 38,814 owned after | $6.48 exercise price | 2026-09-17 | |
| 2026-09-17 holding as of filing | POE BRANDON Officer (Chief Financial Officer) | 4 | Options (Right to Buy) Derivative · Direct | Holding | 117,401 owned after | $5.50 exercise price | 2026-09-17 | |
| 2026-09-17 holding as of filing | SMITH-VAN VURST ANDREW Director, Officer (Chief Operating Officer), 10% Owner | 4 | Options (Right to Buy) Derivative · Direct | Holding | 2,250,000 owned after | $2.00 exercise price | 2026-09-17 | |
| 2026-09-17 holding as of filing | SMITH-VAN VURST ANDREW Director, Officer (Chief Operating Officer), 10% Owner | 4 | Options (Right to Buy) Derivative · Direct | Holding | 114,314 owned after | $10.05 exercise price | 2026-09-17 | |
| 2026-09-17 holding as of filing | SMITH-VAN VURST ANDREW Director, Officer (Chief Operating Officer), 10% Owner | 4 | Options (Right to Buy) Derivative · Direct | Holding | 23,246 owned after | $10.05 exercise price | 2026-09-17 | |
| 2026-09-17 holding as of filing | SMITH-VAN VURST ANDREW Director, Officer (Chief Operating Officer), 10% Owner | 4 | Options (Right to Buy) Derivative · Direct | Holding | 253,304 owned after | $5.50 exercise price | 2026-09-17 | |
| 2026-09-17 holding as of filing | Matuszewski Jason Director, Officer (Chief Executive Officer), 10% Owner | 4 | Options (Right to Buy) Derivative · Direct | Holding | 2,250,000 owned after | $2.00 exercise price | 2026-09-17 | |
| 2026-09-17 holding as of filing | Matuszewski Jason Director, Officer (Chief Executive Officer), 10% Owner | 4 | Options (Right to Buy) Derivative · Direct | Holding | 198,807 owned after | $10.05 exercise price | 2026-09-17 | |
| 2026-09-17 holding as of filing | Matuszewski Jason Director, Officer (Chief Executive Officer), 10% Owner | 4 | Options (Right to Buy) Derivative · Direct | Holding | 40,427 owned after | $10.05 exercise price | 2026-09-17 | |
| 2026-09-17 holding as of filing | Matuszewski Jason Director, Officer (Chief Executive Officer), 10% Owner | 4 | Options (Right to Buy) Derivative · Direct | Holding | 440,529 owned after | $5.50 exercise price | 2026-09-17 | |
| 2026-09-17 holding as of filing | WARRINGTON KENNETH HOWARD JR Director | 4 | Options (Right to Buy) Derivative · Direct | Holding | 7,462 owned after | $1.80 exercise price | 2026-09-17 | |
| 2026-09-17 holding as of filing | FORTUNATO MICHAEL A Officer (Chief Accounting Officer) | 4 | Options (Right to Buy) Derivative · Direct | Holding | 200,000 owned after | $1.07 exercise price | 2026-09-17 | |
| 2026-09-17 holding as of filing | FORTUNATO MICHAEL A Officer (Chief Accounting Officer) | 4 | Options (Right to Buy) Derivative · Direct | Holding | 100,000 owned after | $2.99 exercise price | 2026-09-17 | |
| 2026-09-17 holding as of filing | FORTUNATO MICHAEL A Officer (Chief Accounting Officer) | 4 | Options (Right to Buy) Derivative · Direct | Holding | 11,582 owned after | $15.11 exercise price | 2026-09-17 | |
| 2026-09-17 holding as of filing | FORTUNATO MICHAEL A Officer (Chief Accounting Officer) | 4 | Options (Right to Buy) Derivative · Direct | Holding | 2,340 owned after | $15.11 exercise price | 2026-09-17 | |
| 2026-09-17 holding as of filing | FORTUNATO MICHAEL A Officer (Chief Accounting Officer) | 4 | Options (Right to Buy) Derivative · Direct | Holding | 38,546 owned after | $5.50 exercise price | 2026-09-17 | |
| 2026-09-11 holding as of filing | HASSETT BARRY Officer (Chief Commercial Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | Holding | 11,417 owned after | $14.89 exercise price | 2026-09-11 | |
| 2026-09-11 holding as of filing | HASSETT BARRY Officer (Chief Commercial Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | Holding | 2,427 owned after | $14.89 exercise price | 2026-09-11 | |
| 2026-09-11 holding as of filing | HASSETT BARRY Officer (Chief Commercial Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | Holding | 70,485 owned after | $5.50 exercise price | 2026-09-11 | |
| 2026-08-28 holding as of filing | WARRINGTON KENNETH HOWARD JR Director | 4 | Stock Options (Right to Buy) Derivative · Direct | Holding | 7,462 owned after | $1.80 exercise price | 2026-08-28 | |
| 2026-08-20 holding as of filing | POE BRANDON Officer (Chief Financial Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | Holding | 38,814 owned after | $6.48 exercise price | 2026-08-20 | |
| 2026-08-20 holding as of filing | POE BRANDON Officer (Chief Financial Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | Holding | 117,401 owned after | $5.50 exercise price | 2026-08-20 | |
| 2026-08-20 holding as of filing | FORTUNATO MICHAEL A Officer (Chief Accounting Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | Holding | 200,000 owned after | $1.07 exercise price | 2026-08-20 | |
| 2026-08-20 holding as of filing | FORTUNATO MICHAEL A Officer (Chief Accounting Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | Holding | 100,000 owned after | $2.99 exercise price | 2026-08-20 | |
| 2026-08-20 holding as of filing | FORTUNATO MICHAEL A Officer (Chief Accounting Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | Holding | 11,582 owned after | $15.11 exercise price | 2026-08-20 | |
| 2026-08-20 holding as of filing | FORTUNATO MICHAEL A Officer (Chief Accounting Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | Holding | 2,340 owned after | $15.11 exercise price | 2026-08-20 | |
| 2026-08-20 holding as of filing | FORTUNATO MICHAEL A Officer (Chief Accounting Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | Holding | 38,546 owned after | $5.50 exercise price | 2026-08-20 | |
| 2026-08-14 holding as of filing | SMITH-VAN VURST ANDREW Director, Officer (Chief Operating Officer), 10% Owner | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $2.00 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | SMITH-VAN VURST ANDREW Director, Officer (Chief Operating Officer), 10% Owner | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.05 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | SMITH-VAN VURST ANDREW Director, Officer (Chief Operating Officer), 10% Owner | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.05 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | SMITH-VAN VURST ANDREW Director, Officer (Chief Operating Officer), 10% Owner | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.50 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | GORRELL KATHERINE Officer (CLCO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.60 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | WARRINGTON KENNETH HOWARD JR Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.80 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | HASSETT BARRY Officer (Chief Commercial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $14.89 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | HASSETT BARRY Officer (Chief Commercial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $14.89 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | HASSETT BARRY Officer (Chief Commercial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.50 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | POE BRANDON Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.48 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | POE BRANDON Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.50 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | Matuszewski Jason Director, Officer (Chief Executive Officer), 10% Owner | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $2.00 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | Matuszewski Jason Director, Officer (Chief Executive Officer), 10% Owner | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.05 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | Matuszewski Jason Director, Officer (Chief Executive Officer), 10% Owner | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.05 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | Matuszewski Jason Director, Officer (Chief Executive Officer), 10% Owner | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.50 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | FORTUNATO MICHAEL A Officer (Chief Accounting Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.07 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | FORTUNATO MICHAEL A Officer (Chief Accounting Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $2.99 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | FORTUNATO MICHAEL A Officer (Chief Accounting Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.11 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | FORTUNATO MICHAEL A Officer (Chief Accounting Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.11 exercise price | 2026-08-14 | ||
| 2026-08-14 holding as of filing | FORTUNATO MICHAEL A Officer (Chief Accounting Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.50 exercise price | 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |